| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.13 | 5e-05 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.13 | 7e-05 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.12 | 9e-05 |